Prostate News and Research

RSS

Everyday chemicals linked to increased cancer risk, especially in women

This study identifies links between exposure to chemicals like PFAS, parabens, and phenols and increased cancer risk, particularly among women and across racial groups. The findings spotlight the role of environmental toxins in hormone-related cancers, suggesting new avenues for cancer prevention and mitigation strategies.

24 Sep 2023

Scientists identify mutations in 11 genes associated with aggressive forms of prostate cancer

An international research team led by scientists in the Center for Genetic Epidemiology at the Keck School of Medicine of USC and USC Norris Comprehensive Cancer Center has singled out mutations in 11 genes that are associated with aggressive forms of prostate cancer.

21 Sep 2023

Unlocking the power of mRNA vaccines: From COVID-19 to cancer and beyond

A comprehensive review in Signal Transduction and Targeted Therapy delves into the versatility and effectiveness of mRNA vaccines, from their game-changing role in COVID-19 to potential applications in cancer and rare diseases. Despite drawbacks like stability and high immunogenicity, advancements in vaccine technology have poised mRNA platforms as a robust tool for both preventive and therapeutic interventions.

21 Sep 2023

Study offers new insight into immune cells critical to successful vaccination against SARS-CoV-2

A study has revealed new details about a key population of immune system cells critical to successful vaccination against the pandemic virus, SARS-CoV-2.

21 Sep 2023

New treatment approach effectively treats the most aggressive forms of prostate cancer

Researchers at the University of Chicago Medicine Comprehensive Cancer Center established "proof-of-concept" for a new treatment approach that was able to effectively treat the most aggressive forms of prostate cancer. The treatment showed complete tumor control and long-lasting survival without side effects in a mouse model of advanced prostate cancer.

19 Sep 2023

MGI Partners with National Cancer Centre Singapore to Undergo Comprehensive Genomic Profiling of Asian-Prevalent Cancers

MGI Tech Singapore Pte, Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, recently entered a research partnership with National Cancer Centre Singapore ("NCCS") to facilitate comprehensive, multi-dimensional genomic profiling of Asian-prevalent cancers using MGI's core DNBSEQ™ technology.

From MGI 18 Sep 2023

Turning fish waste into cancer fighters: How abalone viscera peptides could be the next big thing in medicine

Researchers explore the potential of bioactive peptides from abalone fish viscera for their antimicrobial and anticancer properties. The study finds promising activity against various bacterial and fungal strains, as well as cytotoxic effects on prostate cancer cells.

17 Sep 2023

Is maple syrup the ultimate natural sweetener? Researchers say it's more than just tasty!

Scientists explore the myriad benefits of maple syrup, revealing its nutritional, pharmacological, and sensory advantages over traditional sweeteners. From antioxidant and anti-inflammatory properties to controlling blood sugar and even potential anticancer effects, maple syrup is more than just a tasty topping.

14 Sep 2023

AACR Cancer Progress Report provides latest statistics on cancer research and treatment

Today, the American Association for Cancer Research (AACR) released the 13th edition of its annual Cancer Progress Report, which chronicles how basic, translational, and clinical cancer research and cancer-related population sciences-;primarily supported by federal investments in the National Institutes of Health (NIH) and the National Cancer Institute (NCI)-;remain vitally important to improving health and saving lives.

13 Sep 2023

Researchers receive NIH grant to build first-ever digital twin of the bladder

Men ages 50 to 60 have an 80 percent chance of having some degree of bladder outlet obstruction (BOO) due to an enlarged prostate – which causes multiple symptoms that can impact their lives physically and psychologically.

13 Sep 2023

Study helps explain why solid tumors often spread to the spine

The vertebral bones that form the spine are derived from a distinct type of stem cell that secretes a protein favoring tumor metastases, according to a study led by researchers at Weill Cornell Medicine.

13 Sep 2023

Unified and concentrated lung cancer advocacy program results in 25% increase in research funding

A unified and concentrated lung cancer advocacy program in the United States resulted in a 25 percent increase in funding to a U.S.-based lung cancer research program, according to a presentation given today at the International Association for the Study of Lung Cancer 2023 World Conference on Lung Cancer in Singapore.

12 Sep 2023

Effective treatment for lower urinary tract symptoms linked to lower mortality risk in older men

Effective treatment for lower urinary tract symptoms (LUTS) in men aged 50 or older is associated with a lower risk of death over the next few years reports a study in the October issue of The Journal of Urology, an Official Journal of the American Urological Association.

11 Sep 2023

PI3K pathway rewiring drives prostate cancer growth

Experts in cell signaling at the Babraham Institute have identified how prostate cancer cells achieve cell growth free from the usual growth cues and regulators.

11 Sep 2023

Exploring the anti-cancer potential of dark tea

The potential of dark tea in cancer prevention and management.

11 Sep 2023

Is there an association between the COVID-19 pandemic and cancer incidence?

The COVID-19 pandemic influenced cancer incidence.

8 Sep 2023

Rising tide of early-onset cancers: Study predicts alarming increase by 2030

An international study published in BMJ Oncology analyzes the Global Burden of Disease 2019 dataset to explore the rising incidence and mortality rates of early-onset cancers (ages 14-49) worldwide. The study highlights varying cancer burdens by gender and region, identifies lifestyle and environmental risk factors, and predicts a significant increase in early-onset cancer rates by 2030.

7 Sep 2023

COVID-19 pandemic disrupted cancer diagnoses, raising alarms for future healthcare resilience

The COVID-19 pandemic led to a notable decline in new cancer diagnoses in Manitoba, Canada, particularly affecting breast, colon, and rectal cancers. The study highlights the urgent need for healthcare strategies to mitigate the impact of future disruptions on cancer detection and treatment.

6 Sep 2023

New consensus statement provides guidance for use of 177Lu-PSMA radionuclide therapy in mCRPC patients

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has issued a new consensus statement to provide standardized guidance for the selection and management of metastatic castrate-resistant prostate cancer (mCRPC) patients being treated with 177Lu-PSMA radionuclide therapy.

5 Sep 2023

Free online tool could potentially mitigate financial toxicity for some prostate cancer patients

A free online tool could potentially save some prostate cancer patients more than $9,000 in out-of-pocket drug costs, a new study finds.

5 Sep 2023

Prostate News and Research

Everyday chemicals linked to increased cancer risk, especially in women

Scientists identify mutations in 11 genes associated with aggressive forms of prostate cancer

Unlocking the power of mRNA vaccines: From COVID-19 to cancer and beyond

Study offers new insight into immune cells critical to successful vaccination against SARS-CoV-2

New treatment approach effectively treats the most aggressive forms of prostate cancer

MGI Partners with National Cancer Centre Singapore to Undergo Comprehensive Genomic Profiling of Asian-Prevalent Cancers

Turning fish waste into cancer fighters: How abalone viscera peptides could be the next big thing in medicine

Is maple syrup the ultimate natural sweetener? Researchers say it's more than just tasty!

AACR Cancer Progress Report provides latest statistics on cancer research and treatment

Researchers receive NIH grant to build first-ever digital twin of the bladder

Study helps explain why solid tumors often spread to the spine

Unified and concentrated lung cancer advocacy program results in 25% increase in research funding

Effective treatment for lower urinary tract symptoms linked to lower mortality risk in older men

PI3K pathway rewiring drives prostate cancer growth

Exploring the anti-cancer potential of dark tea

Is there an association between the COVID-19 pandemic and cancer incidence?

Rising tide of early-onset cancers: Study predicts alarming increase by 2030

COVID-19 pandemic disrupted cancer diagnoses, raising alarms for future healthcare resilience

New consensus statement provides guidance for use of 177Lu-PSMA radionuclide therapy in mCRPC patients

Free online tool could potentially mitigate financial toxicity for some prostate cancer patients

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News